BP
Ballentine Partners Portfolio holdings
AUM
$6.64B
1-Year Return
16.37%
This Quarter Return
+6.52%
1 Year Return
+16.37%
3 Year Return
+60.04%
5 Year Return
+90.6%
10 Year Return
+147.86%
AUM
$1.41B
AUM Growth
+$113M
(+8.7%)
Cap. Flow
+$31.1M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
72.33%
Holding
283
New
83
Increased
79
Reduced
58
Closed
31
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$21.2M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$7.54M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$3.56M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$2.38M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$2.23M |
Top Sells
| 1 |
FedEx
FDX
|
$15.6M |
| 2 |
Alibaba
BABA
|
$5.43M |
| 3 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
$5.24M |
| 4 |
PepsiCo
PEP
|
$2.27M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
$1.54M |
Sector Composition
| 1 | Financials | 1.8% |
| 2 | Technology | 1.58% |
| 3 | Communication Services | 1.19% |
| 4 | Healthcare | 1.16% |
| 5 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
NVIDIA
NVDA
$4.07T
| $375K | 0.03% |
137,640
-3,440
| -2% | -$9.37K |
|
152
Vanguard Mid-Cap Growth ETF
VOT
$17.5B
| $374K | 0.03% |
3,310
| – | – |
|
153
Goldman Sachs
GS
$223B
| $370K | 0.03% |
1,612
+383
| +31% | +$87.9K |
|
154
Novartis
NVS
$251B
| $370K | 0.03% |
5,549
-626
| -10% | -$41.7K |
|
155
State Street
STT
$32B
| $369K | 0.03% |
+4,650
| New | +$369K |
|
|
TWX
156
DELISTED
Time Warner Inc
TWX
| $368K | 0.03% |
3,776
-73
| -2% | -$7.11K |
|
157
Abbott
ABT
$231B
| $366K | 0.03% |
8,215
+683
| +9% | +$30.4K |
|
158
Biogen
BIIB
$20.6B
| $364K | 0.03% |
1,327
-446
| -25% | -$122K |
|
|
DD
159
DELISTED
Du Pont De Nemours E I
DD
| $364K | 0.03% |
+4,532
| New | +$364K |
|
160
Gilead Sciences
GILD
$143B
| $355K | 0.03% |
5,231
-327
| -6% | -$22.2K |
|
161
Emerson Electric
EMR
$74.6B
| $354K | 0.03% |
+5,922
| New | +$354K |
|
162
Independent Bank
INDB
$3.55B
| $345K | 0.02% |
5,305
| – | – |
|
163
iShares MSCI New Zealand ETF
ENZL
$73.8M
| $342K | 0.02% |
8,100
| – | – |
|
|
ESRX
164
DELISTED
Express Scripts Holding Company
ESRX
| $342K | 0.02% |
5,190
+1,807
| +53% | +$119K |
|
165
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $339K | 0.02% |
43,970
+8,879
| +25% | +$68.5K |
|
166
Lowe's Companies
LOW
$151B
| $339K | 0.02% |
+4,129
| New | +$339K |
|
167
Morgan Stanley
MS
$236B
| $326K | 0.02% |
7,612
+256
| +3% | +$11K |
|
168
Medtronic
MDT
$119B
| $325K | 0.02% |
+4,021
| New | +$325K |
|
169
Norfolk Southern
NSC
$62.3B
| $318K | 0.02% |
+2,846
| New | +$318K |
|
170
Live Oak Bancshares
LOB
$1.75B
| $311K | 0.02% |
14,357
+27
| +0.2% | +$585 |
|
|
SAGE
171
DELISTED
Sage Therapeutics
SAGE
| $310K | 0.02% |
4,360
| – | – |
|
172
TJX Companies
TJX
$155B
| $310K | 0.02% |
+7,858
| New | +$310K |
|
173
Target
TGT
$42.3B
| $309K | 0.02% |
5,597
+112
| +2% | +$6.18K |
|
174
Prudential Financial
PRU
$37.2B
| $307K | 0.02% |
+2,887
| New | +$307K |
|
175
Cognizant
CTSH
$35.1B
| $305K | 0.02% |
+5,116
| New | +$305K |
|